Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 EUR | -1.41% | -10.26% | -51.72% |
04-23 | TheraVet SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-13 | TheraVet SA Announces the Launch of BIOCERA-VET Equine | CI |
Business Summary
At the end of 2023, the company had a portfolio of 2 products in the clinical development phase: Visco-Vet for the treatment of limping associated with osteoarthritis in dogs and Biocera-Vet for osseointegration and bone remodeling.
Number of employees: 8
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Osteoarticular Treatment
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +661.56% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United Kingdom
35.5
%
| - | - | 0 | 35.5 % | - |
Belgium
26.4
%
| 0 | 62.1 % | 0 | 26.4 % | +223.31% |
France
15.1
%
| 0 | 14.4 % | 0 | 15.1 % | +702.03% |
Spain
9.4
%
| - | - | 0 | 9.4 % | - |
United States
4.8
%
| - | - | 0 | 4.8 % | - |
Netherlands
4.2
%
| 0 | 23.6 % | 0 | 4.2 % | +34.63% |
Switzerland
1.2
%
| - | - | 0 | 1.2 % | - |
Portugal
1.0
%
| - | - | 0 | 1.0 % | - |
Ireland
0.8
%
| - | - | 0 | 0.8 % | - |
Italy
0.7
%
| - | - | 0 | 0.7 % | - |
Germany
0.6
%
| - | - | 0 | 0.6 % | - |
Czech Republic
0.5
%
| - | - | 0 | 0.5 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 20/11/17 | |
Rodolphe Lebrun
DFI | Director of Finance/CFO | - | 23/10/23 |
Celine Molle
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sabrina Ena
COO | Chief Operating Officer | - | 30/06/14 |
Julie Winand
BRD | Director/Board Member | - | 21/11/17 |
Julie Schurgers
PRN | Corporate Officer/Principal | - | 31/08/20 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 20/11/17 | |
Simon Wheeler
CHM | Chairman | - | 19/12/21 |
Nesya Goris
BRD | Director/Board Member | - | 19/12/21 |
Director/Board Member | - | 16/12/17 | |
Julie Winand
BRD | Director/Board Member | - | 21/11/17 |
Director/Board Member | - | - |
Company contact information
Sector
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-51.72% | 2.44M | |
-2.53% | 103B | |
+1.87% | 95.28B | |
+1.60% | 22.15B | |
-15.36% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-13.12% | 16.05B | |
+4.15% | 13.68B | |
+35.37% | 12.17B |
- Stock Market
- Equities
- ALVET Stock
- Company TheraVet SA